FGEN - FibroGen - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FibroGen's activity chart (see below) currently has 101 price targets and 87 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 44.02% with an average time for these price targets to be met of 133.39 days.

Most recent stock forecast was given by MATTHEW KELLER from HC WAINWRIGHT on 24-Sep-2025. First documented stock forecast 09-Dec-2014.

Best performing analysts who are covering FGEN - FibroGen:

Joel Beatty Kennen Mackay Difei Yang Terence Flynn Paul Choi

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Aug-2025

$43

$33.78 (366.38%)

$43

1 years 28 days ago
(24-Sep-2025)

0/3 (0%)

$30.62 (247.33%)

Buy

$10

$1.2 (13.64%)

$10

1 years 5 months 8 days ago
(13-May-2025)

3/3 (100%)

$2.52 (33.69%)

87

Sell Since 01-Mar-2022

$15

$5.78 (62.69%)

$50

2 years 2 months 21 days ago
(31-Jul-2024)

9/10 (90%)

$1.5 (11.11%)

144

Hold Since 08-Aug-2023

$50

$40.78 (442.30%)

3 years 2 months 14 days ago
(08-Aug-2023)

1/4 (25%)

$14 (38.89%)

177

Buy Since 27-Jun-2023

$875

3 years 3 months 25 days ago
(27-Jun-2023)

2/4 (50%)

$322.25 (58.30%)

15

Show more analysts

Please expand the browser size to see the chart

What is FGEN (FibroGen) average time for price targets to be met?

On average it took 133 days for the stock forecasts to be reached, with an average price target met ratio of 44.02%.

Which analyst most recently updated their price target on FGEN (FibroGen)?

Matthew Keller

Which analyst has the most public recommendations on FGEN (FibroGen)?

Matthew Keller has 4 price targets and 3 ratings on FGEN

Which analyst is the currently most bullish on FGEN (FibroGen)?

Thomas Shrader with the highest potential upside of $1990.78

Which analyst is the currently most reserved on FGEN (FibroGen)?

Danielle Brill with the lowest potential downside of -$0
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?